Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Devices & Consumables > Left-atrial Appendage Occlusion (LAAO) Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Left-atrial Appendage Occlusion (LAAO) Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-15

Pages: 85 Pages

Report ld: 2643483

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the systemic circulation.

The global market for Left-atrial Appendage Occlusion (LAAO) Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Left-atrial Appendage Occlusion (LAAO) Device include Boston Scientific Corp, AtriCure, Abbott, Biosense Webster, Lifetech Scientific and Append Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Left-atrial Appendage Occlusion (LAAO) Device, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Left-atrial Appendage Occlusion (LAAO) Device by region & country, by Type, and by Application.

The Left-atrial Appendage Occlusion (LAAO) Device market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left-atrial Appendage Occlusion (LAAO) Device.

Market Segmentation

Report Metric
Details
Report Title
Left-atrial Appendage Occlusion (LAAO) Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Market Size Available for Years
2024-2030
Global Left-atrial Appendage Occlusion (LAAO) Device Companies Covered
Boston Scientific Corp
AtriCure
Abbott
Biosense Webster
Lifetech Scientific
Append Medical
Global Left-atrial Appendage Occlusion (LAAO) Device Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Left-atrial Appendage Occlusion (LAAO) Device Market, Segment by Type
Endocardial
Epicardial
Others
Global Left-atrial Appendage Occlusion (LAAO) Device Market, Segment by Application
Hospitals
Outpatient Surgery Center
Heart Clinic
Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Left-atrial Appendage Occlusion (LAAO) Device manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Left-atrial Appendage Occlusion (LAAO) Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Left-atrial Appendage Occlusion (LAAO) Device in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Left-atrial Appendage Occlusion (LAAO) Device Product Introduction
    1.2 Global Left-atrial Appendage Occlusion (LAAO) Device Market Size Forecast
    1.3 Left-atrial Appendage Occlusion (LAAO) Device Market Trends & Drivers
        1.3.1 Left-atrial Appendage Occlusion (LAAO) Device Industry Trends
        1.3.2 Left-atrial Appendage Occlusion (LAAO) Device Market Drivers & Opportunity
        1.3.3 Left-atrial Appendage Occlusion (LAAO) Device Market Challenges
        1.3.4 Left-atrial Appendage Occlusion (LAAO) Device Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Left-atrial Appendage Occlusion (LAAO) Device Players Revenue Ranking (2023)
    2.2 Global Left-atrial Appendage Occlusion (LAAO) Device Revenue by Company (2019-2024)
    2.3 Key Companies Left-atrial Appendage Occlusion (LAAO) Device Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Left-atrial Appendage Occlusion (LAAO) Device Product Offered
    2.5 Key Companies Time to Begin Mass Production of Left-atrial Appendage Occlusion (LAAO) Device
    2.6 Left-atrial Appendage Occlusion (LAAO) Device Market Competitive Analysis
        2.6.1 Left-atrial Appendage Occlusion (LAAO) Device Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Left-atrial Appendage Occlusion (LAAO) Device Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left-atrial Appendage Occlusion (LAAO) Device as of 2023)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Endocardial
        3.1.2 Epicardial
        3.1.3 Others
    3.2 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type
        3.2.1 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value, by Type (2019-2030)
        3.2.3 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Outpatient Surgery Center
        4.1.3 Heart Clinic
        4.1.4 Others
    4.2 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application
        4.2.1 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value, by Application (2019-2030)
        4.2.3 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region
    5.1 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region
        5.1.1 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2019-2024)
        5.1.3 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2025-2030)
        5.1.4 Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        5.2.2 North America Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        5.3.2 Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        5.4.2 Asia Pacific Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        5.5.2 South America Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        5.6.2 Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value
    6.3 United States
        6.3.1 United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.3.2 United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.4.2 Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.5.2 China Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.6.2 Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.7.2 South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.8.2 Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019-2030
        6.9.2 India Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application, 2023 VS 2030

7 Company Profiles
    7.1 Boston Scientific Corp
        7.1.1 Boston Scientific Corp Profile
        7.1.2 Boston Scientific Corp Main Business
        7.1.3 Boston Scientific Corp Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.1.4 Boston Scientific Corp Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.1.5 Boston Scientific Corp Recent Developments
    7.2 AtriCure
        7.2.1 AtriCure Profile
        7.2.2 AtriCure Main Business
        7.2.3 AtriCure Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.2.4 AtriCure Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.2.5 AtriCure Recent Developments
    7.3 Abbott
        7.3.1 Abbott Profile
        7.3.2 Abbott Main Business
        7.3.3 Abbott Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.3.4 Abbott Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.3.5 Biosense Webster Recent Developments
    7.4 Biosense Webster
        7.4.1 Biosense Webster Profile
        7.4.2 Biosense Webster Main Business
        7.4.3 Biosense Webster Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.4.4 Biosense Webster Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.4.5 Biosense Webster Recent Developments
    7.5 Lifetech Scientific
        7.5.1 Lifetech Scientific Profile
        7.5.2 Lifetech Scientific Main Business
        7.5.3 Lifetech Scientific Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.5.4 Lifetech Scientific Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.5.5 Lifetech Scientific Recent Developments
    7.6 Append Medical
        7.6.1 Append Medical Profile
        7.6.2 Append Medical Main Business
        7.6.3 Append Medical Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
        7.6.4 Append Medical Left-atrial Appendage Occlusion (LAAO) Device Revenue (US$ Million) & (2019-2024)
        7.6.5 Append Medical Recent Developments

8 Industry Chain Analysis
    8.1 Left-atrial Appendage Occlusion (LAAO) Device Industrial Chain
    8.2 Left-atrial Appendage Occlusion (LAAO) Device Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Left-atrial Appendage Occlusion (LAAO) Device Sales Model
        8.5.2 Sales Channel
        8.5.3 Left-atrial Appendage Occlusion (LAAO) Device Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Left-atrial Appendage Occlusion (LAAO) Device Market Trends
    Table 2. Left-atrial Appendage Occlusion (LAAO) Device Market Drivers & Opportunity
    Table 3. Left-atrial Appendage Occlusion (LAAO) Device Market Challenges
    Table 4. Left-atrial Appendage Occlusion (LAAO) Device Market Restraints
    Table 5. Global Left-atrial Appendage Occlusion (LAAO) Device Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Left-atrial Appendage Occlusion (LAAO) Device Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Left-atrial Appendage Occlusion (LAAO) Device Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Left-atrial Appendage Occlusion (LAAO) Device Product Type
    Table 9. Key Companies Time to Begin Mass Production of Left-atrial Appendage Occlusion (LAAO) Device
    Table 10. Global Left-atrial Appendage Occlusion (LAAO) Device Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left-atrial Appendage Occlusion (LAAO) Device as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2019-2024) & (%)
    Table 27. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2025-2030) & (US$ Million)
    Table 31. Boston Scientific Corp Basic Information List
    Table 32. Boston Scientific Corp Description and Business Overview
    Table 33. Boston Scientific Corp Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of Boston Scientific Corp (2019-2024)
    Table 35. Boston Scientific Corp Recent Developments
    Table 36. AtriCure Basic Information List
    Table 37. AtriCure Description and Business Overview
    Table 38. AtriCure Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of AtriCure (2019-2024)
    Table 40. AtriCure Recent Developments
    Table 41. Abbott Basic Information List
    Table 42. Abbott Description and Business Overview
    Table 43. Abbott Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of Abbott (2019-2024)
    Table 45. Abbott Recent Developments
    Table 46. Biosense Webster Basic Information List
    Table 47. Biosense Webster Description and Business Overview
    Table 48. Biosense Webster Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of Biosense Webster (2019-2024)
    Table 50. Biosense Webster Recent Developments
    Table 51. Lifetech Scientific Basic Information List
    Table 52. Lifetech Scientific Description and Business Overview
    Table 53. Lifetech Scientific Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of Lifetech Scientific (2019-2024)
    Table 55. Lifetech Scientific Recent Developments
    Table 56. Append Medical Basic Information List
    Table 57. Append Medical Description and Business Overview
    Table 58. Append Medical Left-atrial Appendage Occlusion (LAAO) Device Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Left-atrial Appendage Occlusion (LAAO) Device Business of Append Medical (2019-2024)
    Table 60. Append Medical Recent Developments
    Table 61. Key Raw Materials Lists
    Table 62. Raw Materials Key Suppliers Lists
    Table 63. Left-atrial Appendage Occlusion (LAAO) Device Downstream Customers
    Table 64. Left-atrial Appendage Occlusion (LAAO) Device Distributors List
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
    Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Left-atrial Appendage Occlusion (LAAO) Device Product Picture
    Figure 2. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 4. Left-atrial Appendage Occlusion (LAAO) Device Report Years Considered
    Figure 5. Global Left-atrial Appendage Occlusion (LAAO) Device Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Left-atrial Appendage Occlusion (LAAO) Device Revenue in 2023
    Figure 7. Left-atrial Appendage Occlusion (LAAO) Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Endocardial Picture
    Figure 9. Epicardial Picture
    Figure 10. Others Picture
    Figure 11. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Hospitals
    Figure 14. Product Picture of Outpatient Surgery Center
    Figure 15. Product Picture of Heart Clinic
    Figure 16. Product Picture of Others
    Figure 17. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Left-atrial Appendage Occlusion (LAAO) Device Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Left-atrial Appendage Occlusion (LAAO) Device Sales Value (%), (2019-2030)
    Figure 30. United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Left-atrial Appendage Occlusion (LAAO) Device Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Left-atrial Appendage Occlusion (LAAO) Device Sales Value by Application (%), 2023 VS 2030
    Figure 51. Left-atrial Appendage Occlusion (LAAO) Device Industrial Chain
    Figure 52. Left-atrial Appendage Occlusion (LAAO) Device Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation

Description

LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation. The device mechanically occludes the LAA to prevent LAA thrombus from entering the systemic circulation.

The global market for Left-atrial Appendage Occlusion (LAAO) Device was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Left-atrial Appendage Occlusion (LAAO) Device was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Left-atrial Appendage Occlusion (LAAO) Device include Boston Scientific Corp, AtriCure, Abbott, Biosense Webster, Lifetech Scientific and Append Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Left-atrial Appendage Occlusion (LAAO) Device, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Left-atrial Appendage Occlusion (LAAO) Device by region & country, by Type, and by Application.

The Left-atrial Appendage Occlusion (LAAO) Device market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left-atrial Appendage Occlusion (LAAO) Device.

Market Segmentation

Related Reports

Global Left-atrial Appendage Occlusion (LAAO) Device Market Research Report 2023
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2023-08-05
Pages: 84
USD 2900.00
(Single User License)
Global Left-atrial Appendage Occlusion (LAAO) Device Market Insights, Forecast to 2029
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2023-05-31
Pages: 85
USD 4900.00
(Single User License)
Global Left-atrial Appendage Occlusion (LAAO) Device Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2023-08-05
Pages: 89
USD 3350.00
(Single User License)
Left-atrial Appendage Occlusion (LAAO) Device - Global Market Insights and Sales Trends 2024
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2023-12-19
Pages: 85
USD 3350.00
(Single User License)
Global Left-atrial Appendage Occlusion (LAAO) Device Market Research Report 2024
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2024-02-07
Pages: 77
USD 2900.00
(Single User License)
Global Left-atrial Appendage Occlusion (LAAO) Device Market Insights, Forecast to 2030
LAAO devices are implanted in the heart and are intended to reduce the risk of thromboembolism from
Published: 2024-04-15
Pages: 88
USD 4900.00
(Single User License)
Global Left-atrial Appendage Occlusion (LAAO) Device Market Research Report 2025
The global market for Left-atrial Appendage Occlusion (LAAO) Device was valued at US$ million in the
Published: 2025-01-23
Pages: 79
USD 2900.00
(Single User License)
Left-atrial Appendage Occlusion (LAAO) Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Left-atrial Appendage Occlusion (LAAO) Device was estimated to be worth US$ mi
Published: 2025-01-23
Pages: 94
USD 3950.00
(Single User License)